Role of complete para-aortic lymphadenectomy in endometrial cancer

Current Opinion in Obstetrics and Gynecology

Volumn 21, Issue 1, 2009, Pages 10-14

  Fujimoto, Toshio ^a   Fukuda, Jun ^a   Tanaka, Toshinobu ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Endometrial carcinoma; Lymphadenectomy; Para aortic lymph node; Pelvic lymph node

Indexed keywords

CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CYSTIC LYMPHANGIOMA; DEEP VEIN THROMBOSIS; ENDOMETRIUM CANCER; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMALL INTESTINE OBSTRUCTION; TREATMENT OUTCOME;

AORTA; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 59149084782     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32831ac3ac     Document Type: Review

References (53)

1. National comprehensive cancer network clinical practice guidelines in oncology. http://www.nccn.org/.
2. Watanabe Y, Aoki D, Kitagawa R, et al., Disease Committee of Uterine Endometrial Cancer, Japanese Gynecologic Oncology Group. Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol 2007; 105:325-328.
3. Kilgore LC, Partridge EE, Alvarez RD, et al., Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56:29-33.
4. Takeshima N, Hirai Y, Tanaka N, et al., Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol 1996; 88:280-282.
5. Fanning J. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 2001; 82:371 -374.
6. Larson DM, Broste SK, Krawisz BR. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 1998; 91:355-359.
7. Cragun JM, Havrilesky LJ, Calingaert B, et al., Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005; 23:3668-3675.
8. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998; 71:340-343.
9. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of paraaortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 2000; 76:348-356.
10. Fujimoto T, Nanjyo H, Nakamura A, et al., Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage lllc endometrial cancer. Gynecol Oncol 2007; 107:253-259. This study concluded the therapeutic role of para-aortic lymphadenectomy in patients with two or more positive pelvic lymph-node sites.
11. Mariani A, Dowdy SC, Cliby WA, et al., Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 2006; 101:200-208.
12. Lutman CV, Havrilesky LJ, Cragun JM, et al., Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006; 102:92-97.
13. Chan JK, Cheung MK, Huh WK, et al., Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 2006; 107:1823-1830.
14. Chan JK, Urban R, Cheung MK, et al., Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer 2007; 109:2454-2460.
15. Chuang L, Burke TW, Tornos C, et al., Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995; 58:189-193.
16. Bristow RE, Zahurak ML, Alexander CJ, et al., FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 2003; 13:664-672.
17. Havrilesky LJ, Cragun JM, Calingaert B, et al., Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005; 99:689-695.
18. Creasman WT, Morrow CP, Bundy BN, et al., Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60:2035-2041.
19. McMeekin DS, Lashbrook D, Gold M, et al., Nodal distribution and its significance in FIGO stage lllc endometrial cancer. Gynecol Oncol 2001; 82:375-379.
20. Onda T, Yoshikawa H, Mizutani K, et al., Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 1997; 75:1836-1841.
21. Hirahatake K, Hareyama H, Sakuragi N, et al., A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 1997; 65:82-87.
22. Benedetti-Panici P, Maneschi F, Cutillo G, et al., Anatomical and pathological study of retroperitoneal nodes in endometrial cancer. Int J Gynecol Cancer 1998; 8:322-327.
23. Mariani A, Keeney GL, Aletti G, et al., Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 2004; 92:833-838.
24. Watari H, Todo Y, Takeda M, et al., Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 2005; 96:651-657.
25. Creasman WT, Odicino F, Maisonneuve P, et al., Carcinoma of the corpus uteri. In: Proceedings of the FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 (Suppl 1):S105-S143.
26. COSA-NZ-UK Endometrial Cancer Study Groups. Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 1996; 6:102-107.
27. Mohan DS, Samuels MA, Selim MA, et al., Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998; 70:165-171.
28. Chan JK, Wu H, Cheung MK, et al., The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007; 106:282-288. This study reported that lymphadenectomy is associated with an improved survival in stage I grade 3 and more advanced endometrioid uterine cancer.
29. Girardi F, Petru E, Heydarfadai M, et al., Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993; 49:177-180.
30. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Women's Health 2008; 8:8; review.
31. Horowitz NS, Dehdashti F, Herzog TJ, et al., Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004; 95:546-551.
32. Obermair A, Geramou M, Gücer F, et al., Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 1999; 9:383-386.
33. Kucera E, Kainz C, Reinthaller A, et al., Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest 2000; 49:62-66.
34. Kitchener H, Redman CW, Swart AM, Amos CL, ASTEC Study Group. ASTEC. A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol 2006; 101 (Suppl 1):S21-S22.
35. Mariani A, Webb MJ, Keeney GL, et al., Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182:1506-1519.
36. Carey MS, O'Connell GJ, Johanson CR, et al., Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995; 57:138-144.
37. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal bra-chytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 1997; 38:373-380.
38. Morrow CP, Bundy BN, Kurman RJ, et al., Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40:55-65.
39. Henriksen E. The lymphatic dissemination in endometrial carcinoma. A study of 188 necropsies. Am J Obstet Gynecol 1975; 123:570-576.
40. Burke TW, Levenback C, Tornos C, et al., Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996; 62:169-173.
41. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997; 64:411-417.
42. Mariani A, Dowdy SC, Cliby WA, et al., Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109:11-18.
43. Orr JW Jr, Holimon JL, Orr PF. Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 1997; 176:777-789.
44. Homesley HD, Kadar N, Barrett RJ, Lentz SS. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 1992; 167:1225-1230.
45. Shaw E. Looking through the retrospectoscope in the era of evidence-based medicine. J Clin Oncol 1997; 15:1289-1290.
46. Larson DM, Johnson K, Olson KA. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 1992; 79:998-1001.
47. Keys HM, Roberts JA, Brunetto VL, et al., Gynecologic Oncology Group. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92:744-751.
48. Abu-Rustum NR, Alektiar K, lasonos A, et al., The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006; 103:714-718.
49. Touboul E, Belkacémi Y, Buffat LD, et al., Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients. Int J Radiat Oncol Biol Phys 2001; 50:81 -97.
50. Corn BW, Lanciano RM, Greven KM, et al., Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 1994; 12:510-515.
51. Randall ME, Filiaci VL, Muss H, et al., Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006; 24:36-44.
52. Fanning J, Firestein S. Prospective evaluation of the morbidity of complete lymphadenectomy in endometrial cancer. Int J Gynecol Cancer 1998; 8:270-273.
53. Walker JL, Piedmonte M, Spirtos N, et al., Surgical staging of uterine cancer: randomized phase III trial of laparoscopy vs laparotomy - a Gynecologic Oncology Group Study (GOG): preliminary results. Proc Am Soc Clin Oncol 2006; 24. Abstract 5010.